ncRNA Drives Trastuzumab Resistance in HER2 Tumors
In the relentless battle against HER2-positive breast cancer, trastuzumab (commonly known by its brand name, Herceptin) has long stood as ...
In the relentless battle against HER2-positive breast cancer, trastuzumab (commonly known by its brand name, Herceptin) has long stood as ...
In recent years, the field of oncology has witnessed a remarkable transformation driven by the convergence of nanotechnology and cancer ...
The intricate interplay of cellular communication pathways determines much of human health and disease progression, and among these, the Notch ...
In a groundbreaking advance that could redefine the future of cancer immunotherapy, researchers at UCLA have successfully demonstrated the capacity ...
In a groundbreaking advance that could reshape the therapeutic landscape of one of the deadliest pediatric brain cancers, scientists have ...
A groundbreaking study recently unveiled by Yang, Liu, Yu, and colleagues has shed new light on the intricate molecular mechanisms ...
In a groundbreaking exploration into the intricate dialogue between nerves and cancer cells, recent research has unveiled a remarkable phenomenon: ...
In a groundbreaking advancement that could change the landscape of brain cancer treatment, researchers at Virginia Commonwealth University’s Massey Comprehensive ...
Colorectal cancer (CRC) remains a formidable challenge in contemporary oncology, ranking as the second leading cause of cancer-related deaths in ...
In a groundbreaking advancement poised to revolutionize oncological treatment, scientists at the Spanish National Cancer Research Centre (CNIO) have unveiled ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine